| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/22/2009 | WO2008092591A9 Use of guanidinoacetic acid (salts) combined with betaine and/or choline for producing a health-promoting agent |
| 05/22/2009 | WO2008077557A8 8-ethinylxanthine derivatives as selective a2a receptor antagonists |
| 05/22/2009 | WO2008068593A8 Motilide polymorphs |
| 05/22/2009 | WO2008066803A3 Substituted piperizines for the treatment of pain |
| 05/22/2009 | WO2008049997A8 Indole derivatives, process for the preparation thereof and pharmaceutical compositions containing them |
| 05/22/2009 | WO2008043567A8 2-phenyl indene derivatives useful as estrogen receptor ligands |
| 05/22/2009 | WO2008040548A3 Treatment for non-alcoholic-steatohepatitis |
| 05/22/2009 | WO2008034032A3 Beta-lactam cannabinoid receptor modulators |
| 05/22/2009 | WO2007139970A3 Men1 gene for diagnosis and treatment of diabetes |
| 05/22/2009 | WO2007117778A9 Quinolones useful as inducible nitric oxide synthase inhibitors |
| 05/22/2009 | WO2007059329A3 Methods and compositions for treating cancer |
| 05/22/2009 | WO2007033208A3 Use of indirubin and its derivatives in the treatments of hiv infection and heart failure |
| 05/22/2009 | WO2007022320A3 Bacterial contact inhibition and methods thereof |
| 05/22/2009 | WO2005020913A3 Formulations, conjugates, and combinations of drugs for the treatment of neoplasms |
| 05/22/2009 | CA2743756A1 Inhibitors of pim protein kinases, compositions, and methods for treating cancer |
| 05/22/2009 | CA2743334A1 Methods relating to breathing disorders |
| 05/22/2009 | CA2723883A1 Cbi derivatives subject to reductive activation |
| 05/22/2009 | CA2707418A1 Inhibitors of human immunodeficiency virus replication |
| 05/22/2009 | CA2706556A1 Citrulline-containing beverage |
| 05/22/2009 | CA2705947A1 Carboxamide, sulfonamide and amine compounds for metabolic disorders |
| 05/22/2009 | CA2705922A1 Novel bifunctional compounds which inhibit protein kinases and histone deacetylases |
| 05/22/2009 | CA2705916A1 Benzazepinone compound |
| 05/22/2009 | CA2705884A1 New extracts of deschampsia antarctica desv. with antineoplastic activity |
| 05/22/2009 | CA2705840A1 Compositions comprising stilbene polyphenol derivatives and use thereof for combating the ageing of living organisms and diseases affecting same |
| 05/22/2009 | CA2705838A1 Compositions containing flavanoid polyphenol derivatives, and applications thereof in controlling diseases and ageing of living organisms |
| 05/22/2009 | CA2705835A1 Indole compounds and methods for treating visceral pain |
| 05/22/2009 | CA2705833A1 3,5-substituted indole compounds having nos and norepinephrine reuptake inhibitory activity |
| 05/22/2009 | CA2705820A1 Quinoline derivatives and their use as tyrosine kinase inhibitors |
| 05/22/2009 | CA2705815A1 Topical drugs for use in antifungal therapy |
| 05/22/2009 | CA2705812A1 Brca1-based breast or ovarian cancer prevention agents and methods of use |
| 05/22/2009 | CA2705807A1 Quinoxaline-containing compounds as hepatitis c virus inhibitors |
| 05/22/2009 | CA2705803A1 Macrocyclic tetrazolyl hepatitis c serine protease inhibitors |
| 05/22/2009 | CA2705755A1 Bis-(sulfonylamino) derivatives in therapy 066 |
| 05/22/2009 | CA2705689A1 Trisubstituted furopyrimidines and the use thereof as activators of the ip receptor |
| 05/22/2009 | CA2705681A1 Corticosteroid compositions |
| 05/22/2009 | CA2705642A1 Methods of treating or preventing inflammatory diseases of the intestinal tract |
| 05/22/2009 | CA2705587A1 3-aminosulfonyl substituted indole derivatives and methods of use thereof |
| 05/22/2009 | CA2705586A1 3-heterocyclic substituted indole derivatives and methods of use thereof |
| 05/22/2009 | CA2705579A1 Therapeutic compounds and their use in treating diseases and disorders |
| 05/22/2009 | CA2705562A1 Isoquinoline modulators of atp-binding cassette transporters |
| 05/22/2009 | CA2705547A1 Heterocyclic derivatives as modulators of ion channels |
| 05/22/2009 | CA2705537A1 Treatment of breast cancer with a parp inhibitor alone or in combination with anti-tumor agents |
| 05/22/2009 | CA2705533A1 C-19 steroids for therapeutic uses |
| 05/22/2009 | CA2705529A1 C-19 steroids for cosmetic and further uses |
| 05/22/2009 | CA2705521A1 Heterobifunctional polyethylene glycol reagents |
| 05/22/2009 | CA2705513A1 Novel 1,4-diaza-bicyclo[3.2.2]nonyl pyrimidine derivatives and their medical use |
| 05/22/2009 | CA2705508A1 New polymorphic forms of n-[4-(trifluoromethyl)benzyl]-4-methoxybutyramide |
| 05/22/2009 | CA2705502A1 Phenylpyrazole derivatives |
| 05/22/2009 | CA2705488A1 Therapeutic applications of p53 isoforms in regenerative medicine, aging and cancer |
| 05/22/2009 | CA2705481A1 Cephalomannine derivatives, their preparation, pharmaceutical composition and use thereof |
| 05/22/2009 | CA2705452A1 Mapk/erk kinase inhibitors |
| 05/22/2009 | CA2705422A1 Methods for treating visceral pain |
| 05/22/2009 | CA2705417A1 Treatment of uterine cancer and ovarian cancer with a parp inhibitor alone or in combination with anti-tumor agents |
| 05/22/2009 | CA2705393A1 Beta-lactamase inhibitors |
| 05/22/2009 | CA2705391A1 Methods for identification of jak kinase interacting molecules and for the purification of jak kinases |
| 05/22/2009 | CA2705390A1 Benzimidazoledihydrothiadiazinone derivatives as fructose-1,6-bisphosphatase inhibitors, and pharmaceutical compositions comprising same |
| 05/22/2009 | CA2705389A1 Beta-lactamase inhibitors |
| 05/22/2009 | CA2705376A1 Methods for the regulation of the prostaglandin f synthase (pgfs) activity of akr1b1 and uses thereof |
| 05/22/2009 | CA2705372A1 Preventing or ameliorating agent for skin psoriasis |
| 05/22/2009 | CA2705370A1 Heteroaryloxy quinazoline derivatives |
| 05/22/2009 | CA2705368A1 Azetidines as ep2 antagonists |
| 05/22/2009 | CA2705338A1 Inhibitors of human immunodeficiency virus replication |
| 05/22/2009 | CA2705336A1 Heterocyclic derivatives as modulators of ion channels |
| 05/22/2009 | CA2705318A1 Inhibitors of human immunodeficiency virus replication |
| 05/22/2009 | CA2705312A1 Inhibitors of human immunodeficiency virus replication |
| 05/22/2009 | CA2705294A1 Method of treating arthritis |
| 05/22/2009 | CA2705272A1 Method of determining the probability of a therapeutic response in cancer chemotherapy with cardiac glycoside |
| 05/22/2009 | CA2705164A1 Axl antibodies |
| 05/22/2009 | CA2705163A1 Therapeutic uses of compounds having combined sert, 5-ht3 and 5-ht1a activity |
| 05/22/2009 | CA2704957A1 Compositions for the treatment of gastrointestinal inflammation |
| 05/22/2009 | CA2704946A1 Compositions for the treatment of inflammation of the gastrointestinal tract |
| 05/22/2009 | CA2704943A1 Compositions for the treatment of gastrointestinal inflammation |
| 05/22/2009 | CA2704714A1 Pyridazinone derivatives as parp inhibitors |
| 05/22/2009 | CA2704630A1 Dioxoanthracene sulphonate derivatives |
| 05/22/2009 | CA2704628A1 Aryl- and heteroarylcarbonyl derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use |
| 05/22/2009 | CA2704599A1 4-pyrazolyl-n-arylpyrimidin-2-amines and 4-pyrazolyl-n-heteroarylpyrimidin-2-amines as janus kinase inhibitors |
| 05/22/2009 | CA2704536A1 Crystalline forms of tigecycline hydrochloride |
| 05/22/2009 | CA2704510A1 Solid compositions |
| 05/22/2009 | CA2704436A1 Imidazo[1,2-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors |
| 05/22/2009 | CA2704423A1 Equilibrative nucleoside transporter ent1 inhibitors |
| 05/22/2009 | CA2704261A1 Method of synthesis of morpholino oligomers |
| 05/22/2009 | CA2704258A1 Novel thermosensitive liposomes containing therapeutic agents |
| 05/22/2009 | CA2704074A1 Novel methyl-benzimidazole derivatives |
| 05/22/2009 | CA2703901A1 Heterocyclic derivatives |
| 05/22/2009 | CA2703834A1 Silibinin component for the treatment of hepatitis |
| 05/22/2009 | CA2703814A1 Methods and compositions for treating dry eye |
| 05/22/2009 | CA2703600A1 N-containing heterocyclic compounds |
| 05/22/2009 | CA2703220A1 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same |
| 05/22/2009 | CA2703109A1 Compositions and methods for treating purpura |
| 05/22/2009 | CA2703008A1 Anthelmintic paste comprising praziquantel, a macrolide lactone, cyclodextrin and a thickener |
| 05/22/2009 | CA2702874A1 Drug active in neuropathic pain |
| 05/22/2009 | CA2694318A1 Treatment of human disease conditions and disorders using vitamin k analogues and derivatives |
| 05/21/2009 | US20090133153 Polypeptide participating in pyridoxine biosynthesis, polynucleotide encoding the polypetide and those uses |
| 05/21/2009 | US20090133135 Diagnostic and Therapeutic Target SLC39A11 Proteins for Neurodegenerative Diseases |
| 05/21/2009 | US20090131946 Devices and Methods for the Restoration of a Spinal Disc |
| 05/21/2009 | US20090131890 Protease inhibitors in absorbent articles |
| 05/21/2009 | US20090131857 Method and apparatus for introducing a medicinal dose directly into a mammalian patient's cerebrospinal fluid |
| 05/21/2009 | US20090131705 Practical, Cost-Effective Synthesis of Ubiquinones |
| 05/21/2009 | US20090131696 Reducing Tetracycline Resistance in Living Cells |
| 05/21/2009 | US20090131668 4-oxo-4,6,7,8-Tetrahydro-pyrrolo[1,2-a]pyrazine-6-carboxamide compounds |